Is ABBV Worth Buying in 2026?

ABBVIE INC.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether ABBVIE INC. (ABBV) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.19% over 10 days); RSI 57 — healthy momentum range; strong 1-year return of +35.9%; 3-month momentum positive (+30.5%). Concerns: declining volume on rally — weak conviction (0.65x 30d avg). Currently 0.9% off its 52-week high. Score: +6/7.

Ready to act on this? 📈 Trade on Webull

ABBV is in a confirmed uptrend, trading above both its 50-day ($233.30) and 200-day ($224.01) moving averages. An RSI of 56.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +35.9% compares to +16.5% for SPY (beat the market by 19.4%).

$10,000 invested 1 year ago → $13,591 today
vs. S&P 500 (SPY) — same period beat market by 19.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($224.01)
Above 50-day MA ($233.30)
RSI(14) neutral zone (30–70) — currently 56.8
Positive return (+35.9%)
Within 10% of period high (−0.9%)
Period Range $259.36
$187.62 $261.64
RSI (14) 56.8
0 · OversoldOverbought · 100

Key Metrics

Price$259.36
Period Return+35.9%
Period High$261.64
Period Low$187.62
Drawdown−0.9%
MA-50$233.30
MA-200$224.01
RSI (14)56.8
Avg Volume (30d)8.0M
vs. SPYbeat by 19.4%
Return Rank#261 of 999

Trade ABBV

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers